Hypergalactosemia in early infancy: Diagnostic strategy with an emphasis on imaging

Pediatrics International

Volumn 51, Issue 2, 2009, Pages 276-282

  Kono, Tatsuo ^a   Hiki, Taro ^a   Kuwashima, Shigeko ^a   Hashimoto, Teisuke ^a   Kaji, Yasushi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Citrullinemia; Galactosemia; Hemangioendothelioma; Intervention; Portosystemic shunt

Indexed keywords

CONTRAST MEDIUM; IOFETAMINE I 123; MACROSALB TC 99M; STEROID;

ARTERIOVENOUS MALFORMATION; ARTERIOVENOUS SHUNT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CHOLESTASIS; CITRULLINEMIA; CLINICAL ARTICLE; CLINICAL EVALUATION; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FATTY LIVER; FEMALE; GALACTOSEMIA; GASTROINTESTINAL TRACT SCINTISCANNING; HEMANGIOENDOTHELIOMA; HUMAN; INFANCY; INFANT; INTERVENTIONAL RADIOLOGY; LABORATORY TEST; LIVER CIRCULATION; LIVER DISEASE; LIVER TRANSPLANTATION; LIVER TUMOR; LUNG SCINTISCANNING; MALE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; SEDATION;

CITRULLINEMIA; DIAGNOSTIC IMAGING; EMBOLIZATION, THERAPEUTIC; FATTY LIVER; GALACTOSEMIAS; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; PORTASYSTEMIC SHUNT, SURGICAL; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63549109484     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02692.x     Document Type: Article

References (22)

1. Mizoguchi N, Sakura N, Ono H, Naito K, Hamakawa M. Congenital porto-left renal venous shunt as a cause of galactosaemia. J. Inherit. Metab. Dis. 2001 24 : 72 8.
2. Ono H, Mawatari H, Mizoguchi N, Eguchi T, Sakura N, Hamakawa M. Transient galactosemia detected by neonatal mass screening. Pediatr. Int. 1999 41 : 281 4.
3. Gitzelmann R, Forster I, Willi UV. Hypergalactosaemia in a newborn: Self-limiting intrahepatic portosystemic venous shunt. Eur. J. Pediatr. 1997 156 : 719 22.
4. Nishimura Y, Tajima G, Dwi Bahagia A et al. Differential diagnosis of neonatal mild hypergalactosaemia detected by mass screening: Clinical significance of portal vein imaging. J. Inherit. Metab. Dis. 2004 27 : 11 18.
5. Gitzelmann R, Arbenz UV, Willi UV. Hypergalactosaemia and portosystemic encephalopathy due to persistence of ductus venosus Arantii. Eur. J. Pediatr. 1992 151 : 564 8.
6. Maisawa S, Takasago Y, Oyake Y, Maeta H, Fujiwara T. Patent ductus venosus with hypoplastic right hepatoportal system in a young child born with asymmetric intra-uterine growth retardation. Eur. J. Pediatr. 1992 151 : 569 71.
7. Matsumoto T, Okano R, Sakura N et al. Hypergalactosaemia in a patient with portal-hepatic venous and hepatic arterio-venous shunts detected by neonatal screening. Eur. J. Pediatr. 1993 152 : 990 92.
8. Kim SZ, Marz PL, Laor T, Teitelbaum J, Jonas MM, Levy HL. Elevated galactose in newborn screening due to congenital absence of the portal vein. Eur. J. Pediatr. 1998 157 : 608 9.
9. Fugelseth D, Guthenberg C, Hagenfeldt L, Liestol K, Hallerud M, Lindemann R. Patent ductus venosus does not lead to alimentary galactosaemia in preterm infants. Acta Paediatr. 2001 90 : 192 5.
10. Naito E, Ito M, Matsuura S et al. Type II citrullinaemia (citrin deficiency) in a neonate with hypergalactosaemia detected by mass screening. J. Inherit. Metab. Dis. 2002 2 : 71 6.
11. Tanaka Y, Takayanagi M, Shiratori Y et al. Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver. J. Gastroenterol. 2003 38 : 288 94.
12. Takehara Y, Mori K, Edagawa T et al. Presumed hypoplastic intrahepatic portal system due to patent ductus venosus: Importance of direct occlusion test of ductus venosus under open laparotomy. Pediatr. Int. 2004 46 : 484 6.
13. Sodhi KS, Thapa BR, Walia A, Khandelwal N. Congenital intrahepatic porto-systemic venous shunt with galactosemia. Indian J. Gastroenterol. 2007 26 : 87 8.
14. Riccabona M Modern pediatric ultrasound: Potential applications and clinical significance. A review. Clin. Imaging. 2006 30 : 77 86.
15. Ichikawa T, Nakajima H, Nanbu A, Hori M, Araki T. Effect of injection rate of contrast material on CT of hepatocellular carcinoma. AJR Am. J. Roentgenol. 2006 186 : 1413 18.
16. Shiomi S, Sasaki N, Ikeoka N et al. Usefulness of per-rectal portal scintigraphy with Tc-99m pertechnetate for galactosemia in infants. Ann. Nucl. Med. 1998 12 : 375 8.
17. Shiomi S, Kuroki T, Ueda T et al. Clinical usefulness of evaluation of portal circulation by per rectal portal scintigraphy with technetium-99m pertechnetate. Am. J. Gastroenterol. 1995 90 : 460 65.
18. Kashiwagi T, Azuma M, Ikawa T et al. Portosystemic shunting in portal hypertension: Evaluation with portal scintigraphy with transrectally administered I-123 IMP. Radiology 1988 169 : 137 40.
19. Uchino T, Matsuda I, Endo F. The long-term prognosis of congenital portosystemic venous shunt. J. Pediatr. 1999 135 : 254 6.
20. Ono H, Mawatari H, Mizoguchi N, Eguchi T, Sakura N. Clinical features and outcome of eight infants with intrahepatic porto-venous shunts detected in neonatal screening for galactosaemia. Acta Paediatr. 1998 87 : 631 4.
21. Lebrec D, Capron JP, Dhumeaux D, Benhamou JP. Pulmonary hypertension complicating portal hypertension. Am. Rev. Respir. Dis. 1979 120 : 849 56.
22. Kume N, Suga K, Uchisako H, Matsui M, Shimizu K, Matsunaga N. Abnormal extrapulmonary accumulation of 99mTc-MAA during lung perfusion scanning. Ann. Nucl. Med. 1995 9 : 179 84.